Medical News

RSS

A California consumer group says major insurers coerced employees to lobby

"The nation's two largest health insurers have been pressuring employees to lobby against healthcare reform in Congress in violation of a California law against coerced political activity, a consumer group alleged Wednesday," the Los Angeles Times reports.

3 Sep 2009

New radial head plates to be launched by Medartis at the ASSH, in San Francisco

Medartis, Inc. will introduce the Company’s new Radial Head Plates at this year’s American Society for Surgery of the Hand (ASSH) annual meeting beginning today, September 3, 2009, in San Francisco at the Moscone West Convention Center. During the show, Medartis staff will be on site, Booth #137, to demonstrate and discuss the new product as well as the Company’s expanded line of Medartis products.

3 Sep 2009

Updated Blue Spoon Consulting briefing note available for web download

Blue Spoon Consulting Group, LLC, today updated its briefing note examining the degrading trends in pharmaceutical marketing, and what can be done about it. Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), ‘Pharmaceutical Promotion At Its Productivity Frontier’ is currently the only piece of strategic writing that looks at a total context of change shaping how pharmaceutical companies market and measure performance.

3 Sep 2009

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.

3 Sep 2009

Aetna issues toll-free emergency care numbers for members affected by Southern California wildfire

Aetna (NYSE: AET) is making it easier for members impacted by the wildfires burning in Southern California to refill prescriptions and access employee assistance and behavioral health programs. The company is monitoring the situation carefully, and will re-evaluate its medical and dental policies for members as necessary to help them access care in the fire-impacted county of Los Angeles, where many people face evacuations from their homes.

3 Sep 2009

Optimized turmeric extracts may prevent memory loss

scientists with HerbalScience Group LLC, working with researchers from other organizations and medical institutions, conducted an in-depth study of optimized turmeric extracts, demonstrating that key bioactives in the botanical extracts inhibit aggregation and release of amyloid, a protein fragment considered a prime causal suspect in Alzheimer's disease.

3 Sep 2009

Second-quarter 2009 operating highlights announced by Helicos Biosciences

Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009.

3 Sep 2009

Germany’s BMBF awards NOXXON grant for developing Spiegelmer NOX-A12

NOXXON Pharma AG (NOXXON), clinical-stage developer of L-RNA based scaffolds (Spiegelmers®) that bind their targets conceptually similar to antibodies, announced today that the company was awarded a research grant from Germany’s Federal Ministry of Education and Research (BMBF) under the ministry’s small and medium enterprise innovation initiative (“KMU-Innovativ”).

3 Sep 2009

Biosante and Cell Genesys to merge after stockholders' approval

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.

3 Sep 2009

Biosante Pharmaceuticals and Cell Genesys to hold stockholders meeting for merger approval

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc. (NASDAQ:CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies.

3 Sep 2009

U.S. Department of Labor register apprenticeship programs organized by BlueCross BlueShield

The U.S. Department of Labor has registered information technology apprenticeship programs organized by BlueCross BlueShield of South Carolina with Apprenticeship Carolina(TM), a division of the S.C. Technical College System.

3 Sep 2009

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing proprietary targeted medicines for cancer treatment, today announced that two publications describing clinical data generated with GDC-0449 were published in the current edition of The New England Journal of Medicine (NEJM).

3 Sep 2009

U.S. Department of Health and Human Services to purchase flu products from BD

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has received a significant order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) for the purchase of syringes and needles, sharps collectors and alcohol swabs to be used in national flu pandemic preparedness efforts.

From BD (Becton, Dickinson and Company) 3 Sep 2009

Ecological catalysts to get ibuprofen and naxopren from oil production

The Compuestos de Coordinación y Organometálicos group of the University of Huelva is designing ecological catalysts to get important products such as adhesives, textiles and products with pharmacological, antibiotic or insecticide properties -from hydrocarbons, that is, organic molecules derived from oil production.

3 Sep 2009

China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.

3 Sep 2009

China Sky One Medical submits application to perform clinical trials for two new generic drugs

China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has finished the required research for two new generic drugs for eye treatment and submitted application to the State Food and Drug Administration (SFDA) in China to perform clinical trials.

3 Sep 2009

Criminal pricing of Merck’s HIV/AIDS drug Isentress challenged by the AIDS Healthcare Foundation

As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today unveiled its latest advocacy campaign challenging Merck and Co. Pharmaceuticals over the steep price of its key HIV/AIDS drug, Isentress (raltegravir). The first phase of the public awareness campaign includes a postcard mailer, scheduled to arrive this week in the mailboxes of residents of Whitehouse Station, New Jersey, where Merck is headquartered.

3 Sep 2009

JDA Software helps pharmaceutical companies enhance supply-chain management

Successful supply chain management, including managing demand, planning API and formulation production, packaging and distributing, is a goal shared by all pharmaceutical manufacturers. According to PharmaTech.com, effective supply-chain management is particularly important as the pharmaceutical industry seeks ways to reduce costs, maintain regulatory compliance, and adhere to quality and safety standards.

3 Sep 2009

RCN to partner with University of Illinois Medical Center for Fall Rush campaign

RCN Corporation, a leading provider of all-digital and high definition video, high-speed internet, and premium voice services to residential and small-medium business customers, as well as high-capacity transport services to carrier and large enterprise customers, announced today it will partner with the University of Illinois Medical Center as part of its Fall Rush campaign.

3 Sep 2009

Alliance for Health Reform to brief reporters on the hurdles to a meaningful health reform bill

This briefing, for reporters only, will look at some of the important issues that must be settled if President Obama is to sign a meaningful health reform bill this year.

3 Sep 2009

Medical News

A California consumer group says major insurers coerced employees to lobby

New radial head plates to be launched by Medartis at the ASSH, in San Francisco

Updated Blue Spoon Consulting briefing note available for web download

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

Aetna issues toll-free emergency care numbers for members affected by Southern California wildfire

Optimized turmeric extracts may prevent memory loss

Second-quarter 2009 operating highlights announced by Helicos Biosciences

Germany’s BMBF awards NOXXON grant for developing Spiegelmer NOX-A12

Biosante and Cell Genesys to merge after stockholders' approval

Biosante Pharmaceuticals and Cell Genesys to hold stockholders meeting for merger approval

U.S. Department of Labor register apprenticeship programs organized by BlueCross BlueShield

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

U.S. Department of Health and Human Services to purchase flu products from BD

Ecological catalysts to get ibuprofen and naxopren from oil production

China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate

China Sky One Medical submits application to perform clinical trials for two new generic drugs

Criminal pricing of Merck’s HIV/AIDS drug Isentress challenged by the AIDS Healthcare Foundation

JDA Software helps pharmaceutical companies enhance supply-chain management

RCN to partner with University of Illinois Medical Center for Fall Rush campaign

Alliance for Health Reform to brief reporters on the hurdles to a meaningful health reform bill

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News